(Q45165657)

10 December 2017

Rotavirus vaccines: safety, efficacy and public health impact (English)

1 reference

10 December 2017

0 references

1 reference

J Gray

1

1 reference

PubMed ID

21668823

10 December 2017

language of work or name

English

0 references

publication date

3 July 2011

1 reference

Journal of Internal Medicine

10 December 2017

1 reference

10 December 2017

270

1 reference

10 December 2017

3

1 reference

10 December 2017

206-214

1 reference

Rotavirus genotyping: keeping up with an evolving population of human rotaviruses

10 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Remarkable postvaccination spatiotemporal changes in United States rotavirus activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Rotavirus vaccines in Belgium: policy and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

Pentavalent Rotavirus Vaccine and Prevention of Gastroenteritis Hospitalizations in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02409.X

10.1111/J.1365-2796.2011.02409.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference

PubMed ID

21668823